AD ADUR Aduro Clean Technologies Inc. Common Stock Loading... : Investor Sentiment and Bull/Bear Views

The author argues Aduro's Hydrochemolytic process has been independently validated (cracker-ready oil with no pretreatment, 88.8–90.8% pilot yields) and that its licensing model, funded by C$65.75M cash with zero debt and ~two years of runway, is not reflected in a stock down over 40% from its June high. Catalysts he is watching include progress with TotalEnergies, the March 2026 offtake LOI moving toward binding terms, Saipem advancing from Early Works, and paraffinic crude program results, within the roughly 12–18 months before licensing revenue and FOAK construction targeted for early 2028. Main stated risks: no binding commercial agreements yet, the licensing model remains theory until someone pays, the FOAK plant still needs a final investment decision and cost numbers, and further equity raises are expected.

Author holds ADUR as their largest position and argues the ~$355M market cap with C$65.75M cash and zero debt understates a validated Hydrochemolytic process that produced 88–91% pilot yields and drew Shell and TotalEnergies technical engagement. They see the >40% drawdown from the June high as selling exhaustion rather than a broken story, with the stock around $9.95 and under its January level. Catalysts they are watching include TotalEnergies' next step, the offtake LOI advancing to binding terms, Saipem moving past Early Works, paraffinic program results, and Chemelot permitting, against a 12–18 month path to potential licensing revenue and FOAK construction targeted for early 2028. Main risks are no binding commercial agreements yet, an unproven licensing model, likely future equity raises, and unresolved FOAK cost/FID and long-duration operating risk.